about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsEvaluation of targeted influenza vaccination strategies via population modelingA 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemicsResistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisAmantadine and rimantadine for influenza A in children and the elderlyInterventions for preventing influenza: an overview of Cochrane systematic reviewsNeuraminidase inhibitors for preventing and treating influenza in children (published trials only)Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisAmantadine and rimantadine for influenza A in children and the elderlyNeuraminidase inhibitors for preventing and treating influenza in childrenNeuraminidase inhibitors for preventing and treating influenza in healthy adults and childrenNeuraminidase inhibitors for preventing and treating influenza in healthy adults and children - a review of clinical study reportsInterventions for preventing influenza: an overview of Cochrane systematic reviewsNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisAmantadine and rimantadine for influenza A in children and the elderlyNeuraminidase inhibitors for preventing and treating influenza in childrenZanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory commentsPharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populationsNeuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisAssessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the NetherlandsInfluenza A virus neuraminidase limits viral superinfectionCurrent and future antiviral therapy of severe seasonal and avian influenzaInhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomersModeling human influenza infection in the laboratoryInfluenza treatment and prophylaxis with neuraminidase inhibitors: a reviewInfluenza prevention and treatment in transplant recipients and immunocompromised hostsOseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study DesignStructure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolutionFunctional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemicSynthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylatePeramivir injection in the treatment of acute influenza: a review of the literatureInfluenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological ActivityInvestigation of Carbohydrate Recognition via Computer SimulationA novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cellsNeuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spreadOseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferretsIdentification of a PA-binding peptide with inhibitory activity against influenza A and B virus replicationStructure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo
P2860
Q21090775-D759225C-620E-4370-A3AC-96BF2D35EB68Q21136144-1B9B487F-B17C-4D4D-A0F3-4361628D8AFCQ21245278-F2084024-9636-4CFD-B870-72E1AA4AB142Q22305941-C5489181-7CFA-40B5-8AEE-403F9675B688Q24186108-6BD5755C-6727-4C83-97CD-0CFAA42B62BCQ24187883-2EB9C589-2769-4541-8560-5CAD5F05E804Q24193398-CCD5275B-227F-4B46-B26A-119DD2A670B9Q24200222-7198FAE5-33E2-4F5B-93E6-266BA550E6C5Q24200454-F5A4688E-9345-48A2-AC80-D72CC3FB8072Q24203853-BB7006F1-601A-4285-87BF-ABFA5F14ABD9Q24203875-098EDD04-F257-4211-B755-04E5FFA4B561Q24203905-00F7722A-594F-4E0C-9480-BE1620394FD5Q24235164-30A58841-1241-4F3C-8FCE-7C26E0856985Q24235679-30EAF9BA-9E4C-4707-8EDB-EB12C52FB5EFQ24236654-E26DED9E-1D70-4FE4-9944-52E0F657C6BBQ24241128-E323FCE7-3C34-4ED2-A344-F3592C3A8233Q24242639-FAB4D27C-E579-48AB-8850-00C3B40898FCQ24243136-B976E28F-F5F3-4DFC-B89A-89279930038CQ24568340-A34BB376-9DD2-4BF1-85B2-4B40E1CF7229Q24630906-1B78B58D-4A1A-4421-8347-8B7BE07CAFF7Q24644585-20D7C6A3-DDB7-4C8C-96F7-37D87817EC16Q24645393-8A5180CB-EA18-4606-B688-EF8200DBBCEFQ24656050-6239E130-CE94-41AB-9787-1FAAF2756559Q24656164-B2BE00F9-2353-44A1-9FE2-187C1A9483E4Q24675029-699E4E75-E9CB-4899-868B-B0FCBFA8F9D4Q26781842-E882AF26-E21A-472E-8A1B-0FFB709CF07FQ26860032-48454AA7-D5E6-4AA4-9995-672E10D83A10Q27011595-3A38A6EA-5F03-43CC-BA78-9D6729414C3EQ27317735-68640F24-3A12-4B06-BA05-006707647741Q27650821-D22A129B-078D-4917-9667-979038972C14Q27681276-8D0406DC-771E-4F0B-881C-CF07250FB24CQ27688897-D6C246FA-9F05-4159-974A-03069057A13BQ28068310-0843098C-ECD8-4D93-9529-24016A32BC55Q28079041-FBF17234-AEE6-4AB6-8D4E-748BB9B7ADD2Q28082636-2B7BD5E4-EF48-40DF-8DCA-01C8D3DA5BF7Q28390286-AB8BF3B3-4690-404E-B512-8CF62E54E1E4Q28471814-886B8F36-0A7F-4E2E-AE25-E1BC8BA60E71Q28474889-63CEE63D-C143-4157-B119-76E09B57912CQ28476315-5F88A02C-45E4-4D6E-8C4C-042B4A017ED6Q28476470-8092F3E9-3DDF-4CE0-B5ED-3808FA681B04
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Neuraminidase inhibitors for influenza.
@ast
Neuraminidase inhibitors for influenza.
@en
Neuraminidase inhibitors for influenza.
@nl
type
label
Neuraminidase inhibitors for influenza.
@ast
Neuraminidase inhibitors for influenza.
@en
Neuraminidase inhibitors for influenza.
@nl
prefLabel
Neuraminidase inhibitors for influenza.
@ast
Neuraminidase inhibitors for influenza.
@en
Neuraminidase inhibitors for influenza.
@nl
P356
P1476
Neuraminidase inhibitors for influenza.
@en
P2093
Anne Moscona
P304
P356
10.1056/NEJMRA050740
P407
P577
2005-09-01T00:00:00Z